Direct listing · NTHI

Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc. (NTHI) went public through a direct listing on Nasdaq Global Market on Mar 25, 2025, with a reference price of $12.00. Manatt, Phelps & Phillips advised the company.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company that has developed its own technology and intellectual property portfolio, run preclinical studies and begun clinical trials, in a field where competitors pursue treatments for solid tumors.

Status: Direct listing
Ticker: NTHI
Exchange: Nasdaq Global Market
Listed: Mar 25, 2025
Price: $12.00
First filed: Dec 18, 2023
Company counsel: Manatt, Phelps & Phillips
Sector: Biotech & pharma
Country / state: CA

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 days Open in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Registration statement (S-1) first filed Dec 18, 2023
Latest amendment Feb 26, 2025
Final prospectus (424B4) Mar 25, 2025
All filings on EDGAR CIK 1979414

Other Biotech & pharma direct listings in 2025

Functional Brands Inc.MEHA · Nov 6, 2025
Turn Therapeutics Inc.TTRX · Oct 8, 2025